Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-13

Clinical Trial Update: Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for perillyl alcohol in metastatic prostate cancer after hormone therapy failure. Status: COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perillyl Alcohol (perillyl alcohol)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED